These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 15833035)
1. Reaction kinetics of biotinylated organophosphorus toxicant, FP-biotin, with human acetylcholinesterase and human butyrylcholinesterase. Schopfer LM; Voelker T; Bartels CF; Thompson CM; Lockridge O Chem Res Toxicol; 2005 Apr; 18(4):747-54. PubMed ID: 15833035 [TBL] [Abstract][Full Text] [Related]
2. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Peeples ES; Schopfer LM; Duysen EG; Spaulding R; Voelker T; Thompson CM; Lockridge O Toxicol Sci; 2005 Feb; 83(2):303-12. PubMed ID: 15525694 [TBL] [Abstract][Full Text] [Related]
3. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
4. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase. Bartling A; Worek F; Szinicz L; Thiermann H Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809 [TBL] [Abstract][Full Text] [Related]
5. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069 [TBL] [Abstract][Full Text] [Related]
6. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry. Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663 [TBL] [Abstract][Full Text] [Related]
7. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase. Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306 [TBL] [Abstract][Full Text] [Related]
8. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Quistad GB; Klintenberg R; Casida JE Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of two different cholinesterases by tacrine. Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of aging of mipafox-inhibited butyrylcholinesterase. Kropp TJ; Richardson RJ Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978 [TBL] [Abstract][Full Text] [Related]
11. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity. Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656 [TBL] [Abstract][Full Text] [Related]
12. Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation. Segall Y; Quistad GB; Sparks SE; Casida JE Chem Res Toxicol; 2003 Mar; 16(3):350-6. PubMed ID: 12641435 [TBL] [Abstract][Full Text] [Related]
13. On-site analysis of acetylcholinesterase and butyrylcholinesterase activity with the ChE check mobile test kit-Determination of reference values and their relevance for diagnosis of exposure to organophosphorus compounds. Worek F; Schilha M; Neumaier K; Aurbek N; Wille T; Thiermann H; Kehe K Toxicol Lett; 2016 May; 249():22-8. PubMed ID: 27033775 [TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths]. Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726 [No Abstract] [Full Text] [Related]
15. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467 [TBL] [Abstract][Full Text] [Related]
16. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study. Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253 [TBL] [Abstract][Full Text] [Related]
17. Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds. Aminoff D; Bochar DA; Fuller AA; Mapp AK; Showalter HD; Kirchhoff PD Anal Biochem; 2009 Sep; 392(2):155-61. PubMed ID: 19497294 [TBL] [Abstract][Full Text] [Related]
18. Characteristic mass spectral fragments of the organophosphorus agent FP-biotin and FP-biotinylated peptides from trypsin and bovine albumin (Tyr410). Schopfer LM; Champion MM; Tamblyn N; Thompson CM; Lockridge O Anal Biochem; 2005 Oct; 345(1):122-32. PubMed ID: 16125664 [TBL] [Abstract][Full Text] [Related]
19. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro. Jun D; Musilova L; Kuca K; Kassa J; Bajgar J Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161 [TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]